$2.05
-0.01 (-0.49%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,155.1% upside
Low Target
$15.89
Average Target
$25.73
High Target
$34.39
Current Price
$2.05
Current
$2.05
$2.05
Target
$25.73
$25.73
$15.89
$25.73 avg
$34.39
Scenario Analysis
Bear Case
$15.89
675.1%
Low target
Base Case
$25.73
+1,155.1%
Avg target
Bull Case
$34.39
+1,577.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$27.63
-92.6% from high
52-Week Low
$19.00
+-89.2% from low
Target vs 52W High
$25.73
-6.9% vs high
Next Earnings Report
Mar 5, 2026 · After Market Close
17d
until earnings
EPS Est: $-0.37
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |